Peptivoice

Molecule guide · recovery · updated August 2026

TB-500: thymosin beta-4's fragment, between recovery lore and doping lists

Medically reviewed by Dr. Samuel Ragone · 2026-08-20 · not medical advice

TB-500 rides shotgun to BPC-157 in recovery-stack culture, and shares its profile: rich animal literature, near-zero controlled human evidence, research-chemical supply, and a firm place on the WADA prohibited list. Its one distinction is taxonomic - most buyers don't know they're buying a fragment, not the protein the studies describe.

TB-500 vs thymosin beta-4: not the same thing

Thymosin beta-4 (Tβ4) is a 43-amino-acid protein involved in actin regulation, cell migration, and tissue repair; it has genuine clinical research history (including trials in wound healing and cardiology, mostly discontinued or inconclusive). TB-500 as sold is typically the short active fragment (residues 17-23, LKKTETQ) - cheaper to synthesize, and assumed to carry the repair activity. Most 'TB-500 studies' cited in marketing are actually full-protein Tβ4 studies.

The evidence

  • Animal models: accelerated healing in muscle, tendon, cornea, and cardiac tissue for Tβ4 - a real and interesting literature.
  • Human trials: full Tβ4 has been trialed (dry eye, pressure ulcers, cardiac repair) with mixed or unfinished results; the TB-500 fragment itself has no published controlled human trials.
  • Veterinary shadow: Tβ4/TB-500 has a long history in racehorse doping - much of the practical 'dosing lore' online traces to equine use, not human data.

Sport: treat it as radioactive

TB-500/Tβ4 is prohibited at all times under the WADA list, is explicitly screened in modern anti-doping panels, and has produced sanctions across combat sports, athletics, and racing. Detection windows for the fragment and its metabolites are longer than forum lore suggests. For any tested athlete, this compound is a career risk, full stop.

The dosage math

TB-500 circulates in milligram amounts (typical discussion: 2-5 mg weekly in 'loading' phases - anecdote, not evidence). A 5 mg vial with 2.5 ml of bacteriostatic water gives 2 mg/ml; a 2 mg draw is 1 ml - 100 units, a full large syringe, worth knowing before you reconstitute. More water is impossible past vial capacity, so large doses often mean two draws. The TB-500 calculator flags exactly this.

The BPC-157 stack question

The two are marketed as synergistic ('BPC for local, TB for systemic'). No controlled study - animal or human - has tested the combination. Stacking two compounds that each lack human safety data doesn't halve the unknowns; it compounds them. That's not moralizing, it's arithmetic.

Frequently asked questions

What is TB-500 used for?

In animal research (mostly as full thymosin beta-4): tissue repair across muscle, tendon, cornea, and heart. In gray-market practice: injury recovery, on the strength of that animal work plus anecdote. No controlled human trial supports the fragment as sold.

How long does TB-500 stay in your system?

Anti-doping labs detect Tβ4 fragments and metabolites well beyond the days-long window forum posts claim; exact windows depend on assay and dose and aren't publicly tabulated. Tested athletes should assume detectability for weeks.

Is TB-500 legal?

Not approved, no compounding pathway, sold research-use-only - same framework as BPC-157. Prohibited in essentially all tested sport at all times.

Primary sources